- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04543578
Evaluation of a Protocol for Multidisciplinary Management of Acute Cholecystitis.
Evaluation of the Applicability and Effectiveness of a Protocol for the Multidisciplinary Management of Acute Cholecystitis
Study Overview
Status
Conditions
Detailed Description
Adult patients attending the emergency department and diagnosed with acute cholecystitis will be asked to participate. Those considered not suitable for surgery will be admitted in a medical department and assigned to conservative treatment or cholecystostomy, according to their acute cholecystitis severity. In patients suitable for surgery, risk of concomitant choledocholithiasis will be assessed and patients will be assigned to low risk or intermediate-high risk. The latter will be admitted in a medical department, and choledocholithiasis will be ruled out and treated if present. The former will be offered cholecystectomy or cholecystostomy according to their surgical risk and acute cholecystitis severity. A flowchart with extended information is attached.
PRIMARY OBJECTIVES
• To harmonize the management of acute cholecystitis with a multidisciplinary protocol based on the most recent guidelines.
SECONDARY OBJECTIVES
- To analyze the compliance with this protocol.
- To evaluate the validity of the criteria used in the decision-making process.
- To assess the morbidity and mortality of different groups of patients according to the selected treatment, severity of cholecystitis and baseline characteristics of the patient.
- To estimate the resource use in each group of patients.
- To compare current data with a previous period.
- To adapt and modify the protocol according the study results. INCLUSION CRITERIA
- Patients aged 18 or older who agree to participate (an informed consent signature is required)
- Patients attended in the emergency department of our hospital and diagnosed with acute cholecystitis according to the Tokyo criteria.
EXCLUSION CRITERIA
- Patients under 18 years or patients who refuse to participate in the study
- Patients diagnosed with acute cholangitis during admission for other causes.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Federico Bolado Concejo, MD, PhD
- Phone Number: 0034848422025
- Email: fboladoc@cfnavarra.es
Study Contact Backup
- Name: Ruth Garcia Rey, MS
- Phone Number: 0034848422163
- Email: ruth.garcia.rey@navarra.es
Study Locations
-
-
Navarra
-
Pamplona, Navarra, Spain, 31008
- Recruiting
- Complejo Hospitalario de Navarra
-
Contact:
- Federico Bolado Concejo, MD, PhD
- Phone Number: 848422025
- Email: fboladoc@cfnavarra.es
-
Contact:
- Ruth García Rey, MSc
- Phone Number: 848422163
- Email: ruth.garcia.rey@navarra.es
-
Principal Investigator:
- Federico Bolado Concejo, MD, PhD
-
Sub-Investigator:
- Marian Casi Villaroya, MD
-
Sub-Investigator:
- Lucas Blázquez Lautre, MD
-
Sub-Investigator:
- Pablo Sánchez Acedo, MD
-
Sub-Investigator:
- Cristina Saldaña Dueñas, MD
-
Sub-Investigator:
- Belen González de la Higuera Carnicer, MD
-
Sub-Investigator:
- Erika Borobio Aguilar, MD
-
Sub-Investigator:
- Amaia Arrubla Gamboa, MD
-
Sub-Investigator:
- Bruno Camarero Triana, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged 18 or older who agree to participate (an informed consent signature is required)
- Patients attended in the emergency department of our hospital and diagnosed with acute cholecystitis according to the Tokyo criteria.
Exclusion Criteria:
- Patients under 18 years or patients who refuse to participate in the study
- Patients diagnosed with acute cholangitis during admission for other causes.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients unfit for Surgery with mild-moderate acute cholecyst
Conservative treatment (antibiotics, etc).
EUS-guided gallbladder drainage will be considered in recurrent acute cholecystitis and in patients with no improvement in 48-72h after admission.
|
Patients unfit for Surgery with severe acute cholecystitis
Percutaneous cholecystostomy or Endoscopic Ultrasound (EUS)-guided cholecystostomy (the latter is not 24/7 available).
Palliative care may also be considered in patients with very serious conditions and low life expectancy.
|
Patients suitable for Surgery with high and intermediate risk
Admission in Gastroenterology Department. antibiotic treatment. Close follow-up of posible AC complications. Once choledocholithiasis is solved or ruled our, the patient will be considered for same-admission cholecystectomy or programmed cholecystectomy.
|
Patients suitable for Surgery with low risk
Admission in Surgery Department. According to the AC severity:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inclusion rate
Time Frame: During inclusion period
|
Rate of patients with AC diagnosis registered in the study
|
During inclusion period
|
Protocol compliance
Time Frame: During inclusion period
|
Rate of patients with complete protocol compliance
|
During inclusion period
|
Morbidity in the different subtypes of patients
Time Frame: three months after hospital discharge
|
length of hospital stay, need for unplanned readmissions, recurrent cholecystitis
|
three months after hospital discharge
|
Mortality in the different subtypes of patients
Time Frame: three months after hospital discharge
|
90-day disease-specific mortality
|
three months after hospital discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Protocol compliance failure
Time Frame: every 3 months throughout study completion (up to 1 year)
|
Identify causes of protocol compliance failure
|
every 3 months throughout study completion (up to 1 year)
|
Evaluate the technical success
Time Frame: During inclusion period (up to 1 year)
|
Evaluate clinical success and adverse events of the different treatments.
|
During inclusion period (up to 1 year)
|
Evaluate the accuracy in the diagnosis
Time Frame: three months after hospital discharge or after ERCP
|
Evaluate the accuracy of Magnetic Resonance Cholangiopancreatography (MRCP) and EUS in the diagnosis of concomitant choledocholithiasis
|
three months after hospital discharge or after ERCP
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Federico Bolado Concejo, MD, PhD, Complejo Hospitalario de Navarra
Publications and helpful links
General Publications
- ASGE Standards of Practice Committee; Maple JT, Ben-Menachem T, Anderson MA, Appalaneni V, Banerjee S, Cash BD, Fisher L, Harrison ME, Fanelli RD, Fukami N, Ikenberry SO, Jain R, Khan K, Krinsky ML, Strohmeyer L, Dominitz JA. The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc. 2010 Jan;71(1):1-9. doi: 10.1016/j.gie.2009.09.041. No abstract available.
- Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G, Kozaka K, Endo I, Deziel DJ, Miura F, Okamoto K, Hwang TL, Huang WS, Ker CG, Chen MF, Han HS, Yoon YS, Choi IS, Yoon DS, Noguchi Y, Shikata S, Ukai T, Higuchi R, Gabata T, Mori Y, Iwashita Y, Hibi T, Jagannath P, Jonas E, Liau KH, Dervenis C, Gouma DJ, Cherqui D, Belli G, Garden OJ, Gimenez ME, de Santibanes E, Suzuki K, Umezawa A, Supe AN, Pitt HA, Singh H, Chan ACW, Lau WY, Teoh AYB, Honda G, Sugioka A, Asai K, Gomi H, Itoi T, Kiriyama S, Yoshida M, Mayumi T, Matsumura N, Tokumura H, Kitano S, Hirata K, Inui K, Sumiyama Y, Yamamoto M. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):41-54. doi: 10.1002/jhbp.515. Epub 2018 Jan 9.
- Ansaloni L, Pisano M, Coccolini F, Peitzmann AB, Fingerhut A, Catena F, Agresta F, Allegri A, Bailey I, Balogh ZJ, Bendinelli C, Biffl W, Bonavina L, Borzellino G, Brunetti F, Burlew CC, Camapanelli G, Campanile FC, Ceresoli M, Chiara O, Civil I, Coimbra R, De Moya M, Di Saverio S, Fraga GP, Gupta S, Kashuk J, Kelly MD, Koka V, Jeekel H, Latifi R, Leppaniemi A, Maier RV, Marzi I, Moore F, Piazzalunga D, Sakakushev B, Sartelli M, Scalea T, Stahel PF, Taviloglu K, Tugnoli G, Uraneus S, Velmahos GC, Wani I, Weber DG, Viale P, Sugrue M, Ivatury R, Kluger Y, Gurusamy KS, Moore EE. 2016 WSES guidelines on acute calculous cholecystitis. World J Emerg Surg. 2016 Jun 14;11:25. doi: 10.1186/s13017-016-0082-5. eCollection 2016. Erratum In: World J Emerg Surg. 2016 Nov 4;11:52.
- Chisholm PR, Patel AH, Law RJ, Schulman AR, Bedi AO, Kwon RS, Wamsteker EJ, Anderson MA, Elta GH, Govani SM, Prabhu A. Preoperative predictors of choledocholithiasis in patients presenting with acute calculous cholecystitis. Gastrointest Endosc. 2019 May;89(5):977-983.e2. doi: 10.1016/j.gie.2018.11.017. Epub 2018 Nov 19.
- ASGE Standards of Practice Committee; Buxbaum JL, Abbas Fehmi SM, Sultan S, Fishman DS, Qumseya BJ, Cortessis VK, Schilperoort H, Kysh L, Matsuoka L, Yachimski P, Agrawal D, Gurudu SR, Jamil LH, Jue TL, Khashab MA, Law JK, Lee JK, Naveed M, Sawhney MS, Thosani N, Yang J, Wani SB. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc. 2019 Jun;89(6):1075-1105.e15. doi: 10.1016/j.gie.2018.10.001. Epub 2019 Apr 9.
- Manes G, Paspatis G, Aabakken L, Anderloni A, Arvanitakis M, Ah-Soune P, Barthet M, Domagk D, Dumonceau JM, Gigot JF, Hritz I, Karamanolis G, Laghi A, Mariani A, Paraskeva K, Pohl J, Ponchon T, Swahn F, Ter Steege RWF, Tringali A, Vezakis A, Williams EJ, van Hooft JE. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019 May;51(5):472-491. doi: 10.1055/a-0862-0346. Epub 2019 Apr 3.
- Luk SW, Irani S, Krishnamoorthi R, Wong Lau JY, Wai Ng EK, Teoh AY. Endoscopic ultrasound-guided gallbladder drainage versus percutaneous cholecystostomy for high risk surgical patients with acute cholecystitis: a systematic review and meta-analysis. Endoscopy. 2019 Aug;51(8):722-732. doi: 10.1055/a-0929-6603. Epub 2019 Jun 25.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DIGESTIVO CHN-VBP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Cholecystitis
-
Azienda Ospedaliero, Universitaria PisanaCompletedAcute CholecystitisItaly
-
University Hospital, GhentCompletedUncomplicated Acute CholecystitisBelgium, Qatar
-
Konya Meram State HospitalCompleted
-
The University of Texas Health Science Center at...CompletedAcute Cholecystitis | Chronic CholecystitisUnited States
-
Ain Shams UniversityCompletedCholecystitis | Chronic Calculous Cholecystitis | Acute Calculous CholecystitisEgypt
-
IRCCS Policlinico S. MatteoCompleted
-
Hospital del MarCompletedAcute Cholecystitis
-
South Valley UniversityCompletedAcute CholecystitisEgypt
-
Asklepios Klinik LangenUniversity Hospital FrankfurtCompletedAcute Cholecystitis
-
Istituto Clinico Humanitas Mater DominiRecruiting